Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

Contributed by: Business Wire

Logo

Tags

Technology

Biotechnology

FDA

Health

Apps/Applications

Professional Services

Research

Software

General Health

Data Analytics

Health Technology

Science

Data Management

Clinical Trials

preclinical submission evidence

More Like This

Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management

Driving Pathology Forward: Instem Strengthens Provantis® with Continued Investment and Innovation

Instem Introduces Cloud-Hosted Non-GLP Pathology Module for Provantis

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

Instem Announces Acquisition of RockStep Solutions, Inc.

Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions

PR Newswire associated0

More Than 200 Companies Advance Trial Management with Veeva CTMS